Altos Labs, founded in 2021 and based in Redwood City, California, researches how to restore cell health and resilience through cellular rejuvenation. It launched in January 2022 with a reported $3 billion and acquired senotherapeutics startup Dorian Therapeutics in May 2025.
At a glance
| Price from | Custom |
| Best for | Pharma partners and researchers tracking rejuvenation science |
From Altos Labs's own website.
What stands out
- Largest funding base in the field
- Deep bench of academic scientists
Worth knowing
- No approved product yet
- Discloses little about its pipeline
How it ranks
Altos Labs is ranked 1st of 10 in Best Longevity Startups (Lister Score 96.8).
#1 in Best Longevity Startups · Lister Score 96.8
Altos Labs launched in January 2022 with a reported $3 billion in funding..
| Rank | Best Longevity Startups | Score |
|---|---|---|
| 1 | Altos Labs | 96.8 |
| 2 | NewLimit | 95.6 |
| 3 | Retro Biosciences | 94.3 |
| 4 | Loyal | 93.1 |
| 5 | Function Health | 91.8 |
| 6 | Life Biosciences | 90.4 |
| 7 | Juvenescence | 89.1 |
| 8 | Rubedo Life Sciences | 87.7 |
| 9 | Cambrian Bio | 86.4 |
| 10 | Gameto | 85.0 |
Frequently asked questions
How does Altos Labs rank on Lister?
Altos Labs is ranked 1st of 10 in Best Longevity Startups (Lister Score 96.8).
Appears in
Add this badge to your site
If you work at Altos Labs, paste this code into your website to show where it ranks on Lister. The badge links to the ranking and updates within a day when the rank changes.